drugset
drugset / Trial / NCT00913224

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets

NCT00913224 ↗

Phase 1 Completed 38 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability of Diclofenac Sodium 50 mg enteric-coated tablets.

Timeline

Start
1993-04
Primary completion
1993-04
Completion
1993-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 50 mg —

Indications

No indication recorded.